基本信息
views: 239
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dahlöf has extensive experience in cardiovascular research, pharmacology, drug development, and all phases of clinical trials. He has lectured in these areas internationally and authored over 400 scientific publications. Dahlöf has for many years been an adviser to small and large pharmaceutical companies regarding drug development in all phases from preclinical development to larger lifecycle management studies after registration. Dahlöf has initiated and led several major national and multinational mortality and morbidity studies that have had significance for guidelines in cardiovascular prevention.
Research Interests
Papers共 115 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of the American College of Cardiologyno. 8 (2023): 2036-2036
Zivin J A, Sehra R, Shoshoo A,Albers G W,Bornstein N M,Dahlof B,Kasner S E,Howard G,Shuaib A,Streeter J, Richieri S P,Hacke W,
Strokeno. 11 (2014): 3187-93
Load More
Author Statistics
#Papers: 114
#Citation: 18142
H-Index: 27
G-Index: 114
Sociability: 7
Diversity: 1
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn